Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 4,000 shares at $34.87 ($144K) on 2014-12-01, disclosed to the SEC on 2014-12-02.
Scheduled sale ($144k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.87 | 1,900 | $66K | 46.2% |
| 2 | $36.10 | 1,000 | $36K | 25.2% |
| 3 | $37.44 | 1,100 | $41K | 28.7% |
| Total | $35.88 avg | 4,000 | $144K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |